JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 17, 2004; DOI: 10.1124/jpet.104.070797


0022-3565/04/3113-1211-1217$20.00
JPET 311:1211-1217, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.070797v1
311/3/1211    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X.
Right arrow Articles by Imig, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.
Right arrow Articles by Imig, J. D.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

P2X Receptor-Stimulated Calcium Responses in Preglomerular Vascular Smooth Muscle Cells Involves 20-Hydroxyeicosatetraenoic Acid

Xueying Zhao, John R. Falck, V. Raj Gopal, Edward W. Inscho, and John D. Imig

Vascular Biology Center (X.Z., J.D.I.) and Department of Physiology, Medical College of Georgia, Augusta, Georgia (E.W.I., J.D.I.); and Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas (J.R.F., V.R.G.)

The current study tested the hypothesis that endogenous 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the increase in intracellular calcium ([Ca2+]i) elicited by P2X receptor activation in renal microvascular smooth muscle cells. Vascular smooth muscle cells obtained from rats were loaded with fura-2 and studied using standard single cell fluorescence microscopy. Basal renal myocyte [Ca2+]i averaged 96 ± 5 nM. ATP (10 and 100 µM) increased vascular smooth muscle cell [Ca2+]i by 340 ± 88 and 555 ± 80 nM, respectively. The cytochrome P450 hydroxylase inhibitor, N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS), or the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE), significantly attenuated the peak myocyte [Ca2+]i responses to 10 and 100 µM ATP. ATP (100 µM) increased vascular smooth muscle cell [Ca2+]i by 372 ± 93 and 163 ± 55 nM in the presence of DDMS or 20-HEDE, respectively. The P2X receptor agonist, {alpha},{beta}-methylene-ATP (10 µM), increased myocyte [Ca2+]i by 78 ± 12 nM, and this response was significantly attenuated by DDMS (40 ± 15 nM). In contrast, the vascular smooth muscle cell [Ca2+]i evoked by the P2Y agonist, UTP (100 µM), was not altered by DDMS or 20-HEDE. The effect of 20-HETE on [Ca2+]i was also assessed, and the peak increases in [Ca2+]i averaged 62 ± 12 and 146 ± 70 nM at 20-HETE concentrations of 1 and 10 µM, respectively. These results demonstrate that 20-HETE plays a significant role in the renal microvascular smooth muscle cell [Ca2+]i response to P2X receptor activation.


Received April 29, 2004; accepted August 16, 2004.

Address correspondence to: Dr. John D. Imig, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500. E-mail: jdimig{at}mail.mcg.edu




This article has been cited by other articles:


Home page
HypertensionHome page
E. W. Inscho
Mysteries of Renal Autoregulation
Hypertension, February 1, 2009; 53(2): 299 - 306.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Takeuchi, N. Miyata, M. Renic, D. R. Harder, and R. J. Roman
Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R84 - R89.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.